8:00 – 9:15 am - Opening Session
Halfway Broken or Stuck in Neutral: Pharmacological and Nonpharmacological Options for HFmrHF/HFpEF
Presented by Harleen Singh, UTEP
Residual risk remains a significant concern even after therapeutic optimization in patients with HFmrEF and HFpEF, highlighting the importance of continued assessment and management. Unlike HFrEF, where multiple therapies carry strong guideline recommendations, evidence supporting Class I therapies in HFmrEF and HFpEF is more limited. Moreover, patients with these HF phenotypes often experience a higher and accelerating burden of comorbidities.
9:15 – 9:35 am
Break & Visit with Exhibitors
9:35 – 9:55 am General Session
Articles You May Have Missed
Complicated Urinary Tract Infections: Updates in Guidelines and Pharmacist Roles
Presented by Kendall Tucker, Oregon State University College of Pharmacy
This talk will review updates to the complicated urinary tract infection (cUTI) guidelines, emphasizing changes in drug selection and treatment duration. It will highlight opportunities for pharmacists to optimize antimicrobial therapy. Participants will gain insights into implementing guideline recommendations to enhance antimicrobial stewardship.
Beyond Blood Sugars: GLP-1s in Heart Failure with Preserved Ejection Fraction
Presented by Savannah Hiebel, Kaiser Permanente & Ellie Howie, Kaiser Permanente
Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart failure. Despite its prevalence, treatment options that effectively reduce morbidity and mortality remain limited. Randomized controlled trials have shown promise for GLP-1 receptor agonists in reducing HFpEF symptoms, but the evidence has been underpowered and included few clinical endpoints. Recent studies may provide the critical evidence needed for guideline committees to reconsider and update their formal recommendations on GLP-1 RA use in HFpEF.
10:35 – 10:55 am
Break & Visit with Exhibitors
10:55 – 11:55 am General Session
Identifying Red Flags and Diversion in Pharmacy and Hospital Settings IRC Track: Industry
Presented by DEA
DEA’s presentation will include identifying red flags in a pharmacy setting, both for prescribers and patients. DEA will discuss identifying diversion in a hospital setting, including examples from case studies. We will also provide a refresher on federal rules related medication-assisted-opioid-use-disorder treatment and other topics relevant to the pharmacy and hospital settings.
11:55 am – 12:25 pm
Lunch & Fellowship Awards
12:30 – 1:30 pm Track Sessions
General Track
Integrating neurobiology with pharmacologic strategies, highlighting emerging evidence, limitations, and common pitfalls in BPD care.
Presented by Sean Stanley, MD
Industry Partner Track
Pharmacy Leadership Panel with Industry
Panel: Andrew Albanese, Jeegisha R. Patel, Zach McCall, and Taben Main
Moderator: Jennifer Jordan
Student Track
Charting New Horizons: Pharmacy Careers in Public Health, Tech, and Industry
Pharmacists are leaders beyond the bedside. Hear from panelists working for the Oregon Health Authority, in informatics, industry, and insurance as they share how they’re shaping healthcare in unexpected ways. Learn how you, too, can turn your interests into meaningful career opportunities.
Panel: Andrew Gibler, Jane Zimmer, Janelle Rychlick, and Jenifer Smith
Moderator: Young Yoon Ham
1:35 – 1:55 pm
Afternoon Snack Break
2:00 – 3:00 pm Track Sessions
General Track
Guts and Butts: New and Novel Therapeutics for Management of Chronic Idiopathic Constipation and Inflammatory Bowel Disease
Presented by Jenny Rubinstein, OHSU
Guts and Butts will be a practical, evidence-based presentation highlighting recent advances in therapeutics used in the management of gastrointestinal disorders. The session will review newly approved and emerging treatment options for chronic idiopathic constipation and inflammatory bowel disease,with a focus on novel mechanisms, guidelines and clinical data, with real-world considerations. Attendees will gain insights into optimizing therapy selection to improve patient care in these challenging conditions.
Student Track
Interview Skill-Building Exercise
Presented by Young Yoon Ham
3:00 – 4:00 pm General Session
Introduction to Trauma Informed Care: Theory and Practice
Presented by Carisa Williams, OHSU & Ian Alexander, OHSU
Members from the OHSU Hepatitis C Transitions-to-Treatment Team will present core principles of Trauma Informed Care that can be implemented in any client-facing practice, to promote connection and healing. This session will also include group discussion and real-life examples to better understand and explore how Trauma Informed Care can be utilized.
4:00 pm
Happy Hour & Student Poster Session
